New Key Statistics Module, Z-Score and F-Score
NAS:ASND Key Ratios
| Market Cap $ M | 7,585.74 |
| Enterprise Value $ M | 7,964.84 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 21.24 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 357.00 |
| EPS (TTM) $ | -9.59 |
| Beneish M-Score | -0.51 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -18.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -19.79 |
| EV-to-EBITDA | -20.84 |
| PEG | -- |
| Shares Outstanding M | 56.61 |
| Net Margin (%) | -151.78 |
| Operating Margin % | -109.07 |
| Pre-tax Margin (%) | -149.18 |
| Quick Ratio | 0.54 |
| Current Ratio | 0.83 |
| ROA % (ttm) | -58.50 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -93.12 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.80 |
ASND Number of Guru Trades
ASND Volume of Guru Trades
Gurus Latest Trades with NAS:ASND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ASND is held by these investors
Total 2
Ascendis Pharma A/S Insider Transactions
No Available Data
News about NAS:ASND
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers